Inventor · disambiguated record
Martha Hayden-Ledbetter
Also filed as: HAYDEN-LEDBETTER MARTHA · HAYDEN-LEDBETTER MARTHA S · HAYDEN-LEDBETTER MARTHA SUSAN
33 granted patents·35 pending applications·711 citations·filing 2000–2025
98Inventor score
Files withTHERIPION INC10LEDBETTER JEFFREY A9TRUBION PHARMACEUTICALS INC9UNIV WASHINGTON7EMERGENT PRODUCT DEV SEATTLE6
Top patents by PatentIndex Score
68 records- 0198US12180521B2Paraoxonase fusion polypeptides and related compositions and methodsTHERIPION INC·Filed 2022·Granted Dec 31, 2024·6 cites·22 claims
- 0298US7754208B2Binding domain-immunoglobulin fusion proteinsTRUBION PHARMACEUTICALS INC·Filed 2002·Granted Jul 13, 2010·111 cites·8 claims
- 0397US11306297B2Therapeutic nuclease compositions and methodsUNIV WASHINGTON·Filed 2017·Granted Apr 19, 2022·7 cites·28 claims
- 0497US7118751B1DNA vaccines encoding antigen linked to a domain that binds CD40TRUBION PHARMACEUTICALS INC·Filed 2000·Granted Oct 10, 2006·92 cites·14 claims
- 0596US8841416B2Therapeutic nuclease compositions and methodsLEDBETTER JEFFREY A·Filed 2011·Granted Sep 23, 2014·34 cites·118 claims
- 0696US8147835B2Binding domain-immunoglobulin fusion proteinsLEDBETTER JEFFREY A·Filed 2009·Granted Apr 3, 2012·26 cites·22 claims
- 0795US9005612B2Binding domain-immunoglobulin fusion proteinsLEDBETTER JEFFREY A·Filed 2012·Granted Apr 14, 2015·20 cites·22 claims
- 0895US8937157B2Therapeutic nuclease compositions and methodsUNIV WASHINGTON·Filed 2014·Granted Jan 20, 2015·24 cites·39 claims
- 0995US8409577B2Single chain multivalent binding proteins with effector functionTHOMPSON PETER ARMSTRONG·Filed 2007·Granted Apr 2, 2013·140 cites·17 claims
- 1094US10000745B2Therapeutic nuclease compositions and methodsUNIV WASHINGTON·Filed 2015·Granted Jun 19, 2018·12 cites·22 claims
- 1193US12258596B2Polynucleotides encoding paraoxonase fusion polypeptidesTHERIPION INC·Filed 2024·Granted Mar 25, 2025·0 cites·24 claims
- 1293US8197810B2Binding domain-immunoglobulin fusion proteinsLEDBETTER JEFFREY A·Filed 2010·Granted Jun 12, 2012·18 cites·29 claims
- 1393US8106161B2Binding domain-immunoglobulin fusion proteinsLEDBETTER JEFFREY A·Filed 2005·Granted Jan 31, 2012·19 cites·23 claims
- 1493US7829084B2Binding constructs and methods for use thereofTRUBION PHARMACEUTICALS INC·Filed 2003·Granted Nov 9, 2010·49 cites·4 claims
- 1593US7754209B2Binding constructs and methods for use thereofTRUBION PHARMACEUTICALS·Filed 2003·Granted Jul 13, 2010·54 cites·6 claims
- 1692US9416188B2Molecules that bind CD180, compositions and methods of useTHE UNIV OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2016·Granted Aug 16, 2016·8 cites·7 claims
- 1791US9790479B2Therapeutic nuclease compositions and methodsUNIV WASHINGTON·Filed 2014·Granted Oct 17, 2017·9 cites·84 claims
- 1891US7270960B2Diagnosis of ovarian carcinomasPACIFIC NORTHWEST RES INST·Filed 2002·Granted Sep 18, 2007·33 cites·42 claims
- 1990US11472864B2Polynucleotides encoding APOA1-PON1 fusion polypeptidesTHERIPION INC·Filed 2021·Granted Oct 18, 2022·1 cites·16 claims
- 2090US10202588B2Therapeutic nuclease compositions and methodsLEDBETTER JEFFREY A·Filed 2012·Granted Feb 12, 2019·9 cites·84 claims
- 2190US8188237B2Binding domain-immunoglobulin fusion proteinsLEDBETTER JEFFREY A·Filed 2010·Granted May 29, 2012·9 cites·23 claims
- 2290US2024294889A1Dnase fusion polypeptides and related compositions and methodsTHERIPION INC·Filed 2024·Application pending·0 cites
- 2389US11034944B2Therapeutic nuclease compositions and methodsUNIV WASHINGTON·Filed 2018·Granted Jun 15, 2021·4 cites·30 claims
- 2488US9260529B2Molecules that bind CD180, compositions and methods of useHAYDEN-LEDBETTER MARTHA·Filed 2011·Granted Feb 16, 2016·9 cites·1 claims
- 2586US9101609B2CD37 immunotherapeutic and combination with bifunctional chemotherapeutic thereofTAN PHILIP·Filed 2009·Granted Aug 11, 2015·13 cites·5 claims
- 2683US8853366B2Binding domain-immunoglobulin fusion proteinsLEDBETTER JEFFREY A·Filed 2012·Granted Oct 7, 2014·2 cites·19 claims
- 2782US12435322B2Therapeutic nuclease compositions and methodsUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2022·Granted Oct 7, 2025·0 cites·22 claims
- 2882US2023015291A1Dnase fusion polypeptides and related compositions and methodsTHERIPION INC·Filed 2022·Application pending·0 cites
- 2981US12509501B2Polynucleotides encoding APOA-1 fusion polypeptidesTHERIPION INC·Filed 2025·Granted Dec 30, 2025·0 cites·20 claims
- 3081US2023024372A1Polynucleotides encoding apoa1-rnase fusion polypeptidesTHERIPION INC·Filed 2022·Application pending·0 cites
- 3179US12338466B2Therapeutic nuclease compositions and methodsUNIV WASHINGTON·Filed 2021·Granted Jun 24, 2025·0 cites·30 claims
- 3278US12497604B2RNase-PON1 fusion polypeptides and related compositions and methodsTHERIPION INC·Filed 2025·Granted Dec 16, 2025·0 cites·16 claims
- 3375US2025145977A1Methods for treating rheumatoid arthritis using ctla4-pon1 fusion proteinsTHERIPION INC·Filed 2025·Application pending·0 cites
- 3474US9090712B2Diagnosis of carcinomasHELLSTROM INGEGERD·Filed 2009·Granted Jul 28, 2015·1 cites·2 claims
- 3574US2020354447A1Single-chain multivalent binding proteins with effector functionAPTEVO RES & DEVELOPMENT LLC·Filed 2019·Application pending·0 cites
- 3670US12331102B2APOA-1 fusion polypeptides and related compositionsTHERIPION INC·Filed 2018·Granted Jun 17, 2025·0 cites·30 claims
- 3767US10307481B2CD37 immunotherapeutics and uses thereofGROSMAIRE LAURA S·Filed 2006·Granted Jun 4, 2019·1 cites·14 claims
- 3867US2014227269A1Therapeutic nuclease compositions and methodsUNIV WASHINGTON·Filed 2014·Application pending·0 cites
- 3965US2009175867A1Single-Chain Multivalent Binding Proteins with Effector FunctionTRUBION PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 4064US2013183308A1Therapeutic nuclease compositions and methodsCOMMERCIALIZATION UNIVERSITY OF WA CT FOR·Filed 2013·Application pending·0 cites
- 4164US2013184334A1Therapeutic nuclease compositions and methodsUNIV WA CT FOR COMMERCIALIZATION·Filed 2013·Application pending·0 cites
- 4264US2009214539A1B-cell reduction using cd37-specific and cd20-specific binding moleculesTRUBION PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 4364US2013177561A1Therapeutic nuclease compositions and methodsUW CT FOR COMMERCIALIZATION·Filed 2013·Application pending·0 cites
- 4463US2018118823A1Single-chain multivalent binding proteins with effector functionAPTEVO RES & DEVELOPMENT LLC·Filed 2017·Application pending·0 cites
- 4562US2009074814A1DNA Vaccines Encoding Antigen Linked to a Domain That Binds CD40JEFFREY A LEDBETTER·Filed 2008·Application pending·0 cites
- 4662US2009196870A1Binding constructs and methods for use thereofTRUBION PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 4762US2009104684A1Diagnosis of carcinomasPACIFIC NORTHWEST RES INST·Filed 2007·Application pending·0 cites
- 4862US2007025982A1DNA vaccines encoding antigen linked to a domain that binds CD40TRUBION PHARMACEUTICALS·Filed 2006·Application pending·0 cites
- 4962US2014010809A1Binding domain-immunoglobulin fusion proteinsEMERGENT PRODUCT DEV SEATTLE·Filed 2013·Application pending·0 cites
- 5061US2013336977A1Single-chain multivalent binding proteins with effector functionEMERGENT PRODUCT DEV SEATTLE·Filed 2013·Application pending·0 cites
Showing the top 50 of 68 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Martha Hayden-Ledbetter files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →